Back
NRX Pharmaceuticals Vs. IGC Pharma Industry Stock Comparison
Sell
45
NRXP
NRX Pharmaceuticals
Last Price:
1.26
Seasonality Move:
44.75%
Sell
37
IGC
IGC Pharma
Last Price:
0.36
Seasonality Move:
-1.72%
Sell
45
NRX Pharmaceuticals (NRXP)
is a Sell
Is NRX Pharmaceuticals a Buy, Sell or Hold?
- The current NRX Pharmaceuticals [NRXP] share price is $1.26. The Score for NRXP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NRXP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.36. The Score for IGC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRXP Stock Price Chart
What is NRX Pharmaceuticals's stock price today?
-
The NRX Pharmaceuticals share price today is $1.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRXP is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.36
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IGC is experiencing slight buying pressure.
NRXP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.49 | Sell |
| Chaikin Money Flow: | 51053 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.21 - 1.33) | Sell |
| Bollinger Bands (100): | (1.33 - 2.15) | Sell |
IGC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 44.68 | Sell |
| Chaikin Money Flow: | -31963 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.4) | Sell |
| Bollinger Bands (100): | (0.35 - 0.43) | Sell |
NRXP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.23 | Buy |
| 20-day SMA: | 1.28 | Sell |
| 50-day SMA: | 1.4 | Sell |
| 200-day SMA: | 2.88 | Sell |
| 8-day EMA: | 1.24 | Buy |
| 20-day EMA: | 1.27 | Sell |
| 50-day EMA: | 1.43 | Sell |
| 200-day EMA: | 2.62 | Sell |
IGC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.35 | Buy |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.37 | Sell |
| 200-day SMA: | 0.41 | Sell |
| 8-day EMA: | 0.35 | Buy |
| 20-day EMA: | 0.36 | Sell |
| 50-day EMA: | 0.38 | Sell |
| 200-day EMA: | 0.39 | Sell |
NRX Pharmaceuticals Earnings Growth & NRXP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.36 per share, and an increase next year of $1.17 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
NRX Pharmaceuticals Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IGC Pharma Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||